New graft aims to make dialysis easier for kidney patients

NCT ID NCT07557862

Not yet recruiting Disease control Sponsor: Healionics Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This trial tests a new type of vascular graft, called STARgraft, for people with end-stage kidney disease who need hemodialysis. The graft is placed in the arm to create a reliable access point for dialysis. The study compares STARgraft to a standard graft to see if it works better and causes fewer problems. About 75 adults will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: STARgraft (10401) vascular graft
What this could lead to: If it works, this could provide a more reliable and longer-lasting option for hemodialysis access, reducing the need for repeat procedures.
What could go wrong: This is an early-stage trial with only 75 participants, so results may not apply to everyone. The graft could still fail or cause complications like clotting or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE RENAL DISEASE (ESRD)

Contacts and locations

Locations

Afya Hospital Dia, Brasília.

Brasília, Brazil
Clinica Farallones

Cali, Colombia
Hospital Ana Nery

Salvador, Brazil
Hospital Baía Sul

Florianópolis, Brazil
Medellín Clinic - El Poblado

Medellín, Colombia
Pedro Ernesto University Hospital

Rio de Janeiro, Brazil
Royal Portuguese Beneficent Hospital in Pernambuco

Recife, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.